Cerhum

Cerhum is a Belgian company focused on advanced 3D printing of bioceramic materials for medical applications, particularly in bone repair and regeneration. Established in 2015 as a spin-out from Sirris, Cerhum utilizes over a decade of expertise in ceramic additive manufacturing to create innovative, patient-specific bone grafts and implants. The company's flagship product, MyBone® Custom, is a 3D-printed bioceramic bone graft designed for maxillofacial surgery and orthopedic uses. Made from hydroxyapatite, a biocompatible material that mimics natural bone, MyBone® features a patented porous structure that enhances blood vessel growth, promoting faster healing and bone integration compared to traditional graft materials. Cerhum also provides services such as advising on ceramic materials, producing 3D-printed ceramic parts, and manufacturing personalized implants based on surgeons' scans, all while adhering to ISO 13485-2016 standards for medical device production. In addition to medical applications, Cerhum serves industries like electronics, aerospace, and luxury goods, showcasing its expertise in ceramic additive manufacturing. The company is led by CEO Grégory Nolens and collaborates with academic institutions and industry partners to advance personalized implant solutions.

• Employees 22
• Founded 2015